# Revonto

NDC: 84549-003
Generic name: dantrolene sodium
Labeler / Manufacturer: ProPharma Distribution
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20210409

FDA application: ANDA078378

## Active ingredients

- DANTROLENE SODIUM: 20 mg/60mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"84549-003"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=84549-003
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3edcfad5-00ad-7587-e063-6394a90addf3